Topotecan hydrochloride

Catalog #: 4562
6 Citations Datasheet

Catalog #	Availability	Size / Price	Qty
4562/10
4562/50

Topotecan hydrochloride | CAS No. 119413-54-6 | DNA Topoisomerase Inhibitors

1 Image

Description: DNA topoisomerase I inhibitor; Camptothecin (Cat. No. 1100) analog

Alternative Names: SK&F 104864-A

Chemical Name: 10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione hydrochloride

Purity: ≥98%

View All Products for DNA Topoisomerase Inhibitors

Product Details

Citations (6)

Supplemental Products

Reviews

Biological Activity Technical Data Background Product Datasheets Calculators

Biological Activity

Topotecan hydrochloride is a DNA topoisomerase I inhibitor; induces rapid apoptotic death in human B-lineage acute lymphoblastic leukemia (ALL) cells. Improves survival in three mouse models of poor prognosis ALL; downregulates B-Myb and MycN expression in neuroblastoma cells. Water-soluble analog of Camptothecin (Cat. No. 1100). Orally bioavailable. Topotecan disrupts the interaction between NHP2L1 and U4 RNA by binding to U4 and inhibits RNA splicing.

Technical Data

M.Wt:

457.91

Formula:

C₂₃H₂₃N₃O₅.HCl

Solubility:

Soluble to 100 mM in water and to 100 mM in DMSO

Purity:

≥98%

Storage:

Store at -20°C

CAS No:

119413-54-6

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.

Background References

Bioavailability and pharmacokinetics of oral topotecan: a new topoisomerase I inhibitor.
Schellens et al.
Br.J.Cancer, 1996;73:1268
A chemical screen identifies the chemotherapeutic drug topo. as a specific inhibitor of the B-MYB/MYCN axis in neuroblastoma.
Sottile et al.
Oncotarget., 2012;3:535

Product Datasheets

COA view current batch

Or select another batch:

View Batch

SDS

Citations for Topotecan hydrochloride

The citations listed below are publications that use Tocris products. Selected citations for Topotecan hydrochloride include:

6 Citations: Showing 1 - 6

Ion Channel Drugs Suppress Cancer Phenotype in NG108-15 and U87 Cells: Toward Novel Electroceuticals for Glioblastoma.
Authors: Jen Q Et al.
Cancers (Basel) 2022;14
Loss of Aurora Kinase Signaling Allows Lung Cancer Cells to Adopt Endoreplication and Form Polyploid Giant Cancer Cells That Resist Antimitotic Drugs.
Authors: Michael G Et al.
Cancer Res 2021;81:400-413
ATM orchestrates the DNA-damage response to counter toxic non-homologous end-joining at broken replication forks.
Authors: Balmus Et al.
Nat Commun 2019;10:87
Calcium-regulatory proteins as modulators of chemotherapy in human neuroblastoma.
Authors: Florea Et al.
Oncotarget 2017;8:22876
Molecular Phenotyping Combines Molecular Information, Biological Relevance, and Patient Data to Improve Productivity of Early Drug Discovery.
Authors: Martin Et al.
Cell Chem Biol 2017;24:624-634.e3
Identification of chemicals that mimic transcriptional changes associated with autism, brain aging and neurodegeneration.
Authors: Pearson Et al.
Int J Mol Med 2016;7:11173

FAQs

No product specific FAQs exist for this product, however you may

View all Small Molecule FAQs

Reviews for Topotecan hydrochloride

There are currently no reviews for this product. Be the first to review Topotecan hydrochloride and earn rewards!

Have you used Topotecan hydrochloride?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Tocris Bioscience is the leading supplier of novel and exclusive tools for life science research with over 30 years' experience in the industry. Tocris is a Bio-Techne brand.